{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:46:04Z","timestamp":1765295164109,"version":"3.44.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.urology.2020.07.045","type":"journal-article","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T10:56:43Z","timestamp":1596884203000},"page":"152-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Patterns of Initial Metastatic Recurrence After Surgery for High-Risk Nonmetastatic Renal Cell Carcinoma"],"prefix":"10.1016","volume":"146","author":[{"given":"Leo D.","family":"Dreyfuss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viraj A.","family":"Master","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay D.","family":"Raman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe E.","family":"Spiess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shane A.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne B.","family":"Merrill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles C.","family":"Peyton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhyana","family":"Sankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Sohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dattatraya","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel D.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn O.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Jason","family":"Abel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2020.07.045_bib0001","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1056\/NEJMoa1611406","article-title":"Adjuvant sunitinib in high-risk renal-cell carcinoma after nephrectomy","volume":"375","author":"Ravaud","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2020.07.045_bib0002","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(16)00559-6","article-title":"Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial","volume":"387","author":"Haas","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.urology.2020.07.045_bib0003","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/annonc\/mdr362","article-title":"Distribution of metastatic sites in renal cell carcinoma: a population-based analysis","volume":"23","author":"Bianchi","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urology.2020.07.045_bib0004","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2214\/AJR.07.2077","article-title":"Imaging in metastatic renal cell carcinoma","volume":"189","author":"Griffin","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.urology.2020.07.045_bib0005","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1200\/JCO.2015.61.8009","article-title":"Oncologic surveillance after surgical resection for renal cell carcinoma: a novel risk-based approach","volume":"33","author":"Stewart-Merrill","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2020.07.045_bib0006","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.juro.2013.04.121","article-title":"Follow-up for clinically localized renal neoplasms: AUA guideline","volume":"190","author":"Donat","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.07.045_bib0007","doi-asserted-by":"crossref","first-page":"804","DOI":"10.6004\/jnccn.2017.0100","article-title":"Kidney cancer, version 2.2017, NCCN clinical practice guidelines in oncology","volume":"15","author":"Motzer","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.urology.2020.07.045_bib0008","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.eururo.2019.02.011","article-title":"European association of urology guidelines on renal cell carcinoma: the 2019 update","volume":"75","author":"Ljungberg","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2020.07.045_bib0009","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/cncr.11234","article-title":"Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials","volume":"97","author":"Leibovich","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2020.07.045_bib0010","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1200\/JCO.2002.05.111","article-title":"Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma","volume":"20","author":"Zisman","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2020.07.045_bib0011","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1200\/JCO.2014.56.5416","article-title":"Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines","volume":"32","author":"Stewart","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2020.07.045_bib0012","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41585-018-0034-9","article-title":"An interdisciplinary consensus on the management of bone metastases from renal cell carcinoma","volume":"15","author":"Grunwald","year":"2018","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urology.2020.07.045_bib0013","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1080\/14737140.2018.1520097","article-title":"Treating patients with renal cell carcinoma and bone metastases","volume":"18","author":"Guida","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.urology.2020.07.045_bib0014","doi-asserted-by":"crossref","first-page":"e83026","DOI":"10.1371\/journal.pone.0083026","article-title":"Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey","volume":"8","author":"Santini","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.urology.2020.07.045_bib0015","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/annonc\/mdv289","article-title":"Prospective study evaluating the relative sensitivity of 18F-NaF PET\/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design","volume":"26","author":"Gerety","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urology.2020.07.045_bib0016","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/mrm.27117","article-title":"Whole-body MRI for metastatic cancer detection using T","volume":"80","author":"Wang","year":"2018","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.urology.2020.07.045_bib0017","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.clgc.2013.04.012","article-title":"Prognostic factors of survival for patients with metastatic renal cell carcinoma with brain metastases treated with targeted therapy: results from the international metastatic renal cell carcinoma database consortium","volume":"11","author":"Vickers","year":"2013","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urology.2020.07.045_bib0018","doi-asserted-by":"crossref","first-page":"e1163","DOI":"10.1016\/j.clgc.2019.08.006","article-title":"Brain metastasis from renal-cell carcinoma: an institutional study","volume":"17","author":"Suarez-Sarmiento","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urology.2020.07.045_bib0019","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.clgc.2018.11.007","article-title":"Improved survival outcomes for kidney cancer patients with brain metastases","volume":"17","author":"Bowman","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urology.2020.07.045_bib0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11912-020-0892-1","article-title":"Current state of systemic therapies for advanced renal cell carcinoma","volume":"22","author":"Gulati","year":"2020","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.urology.2020.07.045_bib0021","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa1712126","article-title":"Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma","volume":"378","author":"Motzer","year":"2018","journal-title":"N Engl J Med"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429520309584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429520309584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T02:11:58Z","timestamp":1758766318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429520309584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":21,"alternative-id":["S0090429520309584"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2020.07.045","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of Initial Metastatic Recurrence After Surgery for High-Risk Nonmetastatic Renal Cell Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2020.07.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}